ArticleCureus2025
Synchronous Primary Lung Cancer: An Unusual Triple Presentation.
Article in Cureus, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
This case report describes the case of a 75-year-old woman, a former smoker, who began to experience progressive fatigue and shortness of breath. She underwent some tests that did not reveal any significant changes. Still, as the complaints persisted, a computed tomography (CT) scan of the chest was performed, which showed the existence of three suspicious lung lesions, two in the right lung (upper lobe and middle lobe) and one in the left lower lobe. The three lesions were biopsied, which revealed lesions that were positive for CK7 and TTF-1 and negative for p40, suggestive of lung adenocarcinoma. The case was discussed in a multidisciplinary meeting, and the existence of synchronous multiple primary lung cancers (SMPLC) was assumed; hence, it was decided to perform a right bilobectomy and left lower lobe stereotactic body radiation therapy (SBRT). Histology revealed that all the tumors were different, and this was a case of three SMPLC. Despite their rarity, synchronous lung tumors are increasingly diagnosed, bringing with them numerous diagnostic and therapeutic dilemmas, since their overall survival is superior to that of multiple lung metastases from lung carcinoma.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.